More Healthcare Coverage

  • November 19, 2025

    Pharmacy Co., Ex-Worker Resolve Overtime Suit

    A New Jersey company that provides pharmacy services to long-term care facilities and a former hourly employee have reached a settlement in principle to end a proposed collective action alleging it failed to include shift differentials or bonuses in overtime wage calculations.

  • November 18, 2025

    4th Circ. Restores Trade Secrets Suit Against Insurance Execs

    The Fourth Circuit on Tuesday revived insurer Sherbrooke Corp.'s claims of trade secrets theft against three former executives, disagreeing with a district judge who found that the company had not made enough of an effort to guard the software in question.

  • November 17, 2025

    Medtronic Can't Nix FCA Claims Despite 1st Circ. Precedent

    A Massachusetts federal judge reconsidered reviving Medtronic's bid to defeat claims it violated the False Claims Act in light of new First Circuit precedent on a causation standard, but ruled that a whistleblower's evidence warranted keeping the claims alive for now.

  • November 17, 2025

    Texas Court Says Hospital Sex Assault Isn't Medical Claim

    A Texas appeals court has found that allegations that a hospital staffer sexually assaulted a minor patient do not constitute medical liability claims, saying the family of the patient do not need an expert report to continue the case under state law.

  • November 17, 2025

    Pa. Supreme Court Snapshot: Skill Games Top Nov. Lineup

    The Pennsylvania Supreme Court's November session will tackle the legality of the "Pennsylvania Skill" games that have popped up in gas stations and convenience stores, answering the long-simmering question of whether they should be regulated like slot machines. Here are some of the cases the state supreme court will hear during its three-day session in Harrisburg.

  • November 17, 2025

    Mich. Doctor Gets 18 Months For $16M Drug Resale Scheme

    A Michigan doctor was sentenced Monday to spend a year and a half in prison for his role in a scheme to purchase $16 million worth of cancer drugs and resell them at a profit, with a federal judge saying white collar sentences can "deter more" than other criminal sentences.

  • November 13, 2025

    Maya Kowalski Fights Fla. Appeals Court's $213M Reversal

    The subject of the Netflix documentary "Take Care of Maya" has asked a Florida appeals court to reconsider its decision reversing a $213 million judgment, saying the court needs to clarify how far the immunity that state law grants to those who report possible child abuse extends.

  • November 10, 2025

    Law360 MVP Awards Go To Top Attorneys From 76 Firms

    The attorneys chosen as Law360's 2025 MVPs have distinguished themselves from their peers by securing significant achievements in high-stakes litigation, complex global matters and record-breaking deals.

  • November 10, 2025

    Kochava, Class Seek Final OK For Location Data Settlement

    Mobile device users have come to terms with data analytics provider Kochava to end their claims that the company had been selling their geolocation data without proper consent after nearly three years of litigation.

  • November 10, 2025

    GTCR's $627M Medical Coatings Acquisition Can Get Moving

    GTCR BC Holdings LLC can continue with its plan to acquire the nation's leading medical coatings supplier and merge it with the nation's second leading provider while federal regulators challenge the transaction in-house, an Illinois federal judge said Monday, refusing to halt the deal.

  • November 10, 2025

    Fired Cancer Center Worker's ADA Suit Kicked To Pa. Court

    A New Jersey federal judge ruled Monday that a disability bias suit brought by a former worker for the Philadelphia-based Fox Chase Cancer Center belongs in Pennsylvania federal court because her New Jersey-based remote work arrangement wasn't enough to tether the case to the Garden State. 

  • November 07, 2025

    Jury Clears Novo Nordisk Of Medicaid Fraud Over Blood Drug

    A Tacoma federal jury cleared Novo Nordisk on Friday of allegations that it defrauded Washington state's Medicaid and Medicare systems by paying kickbacks and promoting off-label use to illegally boost prescriptions of its hemophilia drug NovoSeven.

  • November 06, 2025

    'Send A Message' To Novo Nordisk Over Kickbacks, Jury Told

    Counsel for a whistleblower claiming Novo Nordisk paid illegal kickbacks to boost off-label prescribing of its hemophilia drug NovoSeven urged jurors during closing arguments Thursday to "send a message" to the drugmaker, saying it defrauded Washington state's Medicaid and Medicare systems out of nearly $100 million.

  • November 06, 2025

    Sutter Health Patients' Attys To Get Over $100M Fees, Costs

    A California U.S. magistrate judge said Thursday that she is ready to grant final approval of a $228.5 million deal settling a 13-year case over claims that Sutter Health boosted costs by pushing all-or-nothing networks on insurers, which includes $75.4 million in attorney fees and over $28 million in litigation expenses.

  • November 05, 2025

    Hawaii Lab Accused Of Hiding Assets To Skirt $8M Judgment

    A Colorado woman who owns three healthcare companies in Hawaii is facing a lawsuit in Colorado state court accusing her of transferring assets and using business funds to evade paying more than $8 million as part of a judgment in a breach of contract case in Hawaii federal court.

  • November 05, 2025

    Mallinckrodt Faces Antitrust Suit Over Oxycodone Supply Halt

    A generic-drug company has claimed in a lawsuit filed in Pennsylvania federal court that Mallinckrodt LLC and a subsidiary have cut off the supply of active ingredients necessary to make competing drugs that include oxycodone and acetaminophen.

  • November 04, 2025

    Dad Expands Wrongful Death Claims In Ketamine Overdose Suit

    A father who claims his 27-year-old son died of a ketamine overdose due to the negligent practices of online therapy provider Mindbloom has added Illinois-based specialty pharmacy chain Optio Rx LLC as a defendant in his North Carolina state lawsuit, claiming it is liable for compounding, manufacturing and shipping the dangerously "unpredictable drug."

  • November 03, 2025

    Harvard Prof Says Novo's Influence Didn't Boost Prescriptions

    A Harvard Medical School professor defended Novo Nordisk on Monday against allegations that it defrauded Washington state's Medicaid system by inducing doctors to overprescribe its hemophilia medication NovoSeven, testifying that his analysis showed the drugmaker's relationships with influential doctors didn't appear to increase prescriptions.

  • November 03, 2025

    NJ Justices Unsure Charity Immunity Applies To Clinic

    New Jersey Supreme Court justices appeared open on Monday to reviving a community health clinic patient's injury suit, questioning whether the organization's archived web pages and general claims of patient education qualified it for protection under the state's Charitable Immunity Act.

  • November 03, 2025

    Mich. Judge OKs $100M+ Deal For Victims Of Doc's Sex Abuse

    A Michigan state judge on Friday approved a settlement worth more than $100 million to resolve a class action from thousands of patients who allege they were sexually abused or recorded by an independent doctor at Henry Ford Macomb Hospital.

  • November 03, 2025

    Removal Dooms Brown Univ. Prof's Habeas Bid, Judge Rules

    A Lebanese professor at Brown University has seen her challenge to a five-year ban on reentering the United States dismissed as a Massachusetts federal judge ruled that her deportation leaves the court without any jurisdiction.

  • October 31, 2025

    Up Next At High Court: Tariffs, Fugitives & Contractor Liability

    The U.S. Supreme Court will begin its November oral argument session Monday, during which the justices will consider President Donald Trump's authority to impose tariffs on foreign countries under an emergency statute, whether military contractors can be held liable for alleged breaches of contracts in war zones, and if there are time limits for litigants who want to vacate a void judgment. Here, Law360 breaks down the week's oral arguments.

  • October 31, 2025

    Opioids Didn't Weigh Heavily In Finances, Hospital Execs Say

    A Florida state court jury heard the start of major pharmacy chains' defense case Friday over allegations that they fueled the opioid crisis and sent Florida hospitals' costs soaring, with testimony from former hospital executives saying the cost of opioid treatment didn't loom large in their financial decisions.

  • October 30, 2025

    7th Circ. Won't Revive Antitrust Suit Against Psychiatry Board

    A split Seventh Circuit panel affirmed the dismissal of an antitrust suit Wednesday from a proposed class of psychiatrists and neurologists challenging the American Board of Psychiatry and Neurology's certification maintenance requirement, finding the plaintiffs failed to allege an illegal tying scheme.

  • October 29, 2025

    Pharmacies Say $1.5B Damages Too Much In Fla. Opioid Suit

    CVS, Walgreens and Walmart on Wednesday grilled an economics expert witness over his opinion that they owe as much as $1.5 billion to a group of Florida hospitals that treated opioid-harmed patients, with defense counsel suggesting damages shouldn't be based on the full sticker price of the medical care.

Expert Analysis

  • Law School's Missed Lessons: Navigating Client Trauma

    Author Photo

    Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.

  • 4 Former Justices Would Likely Frown On Litigation Funding

    Author Photo

    As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.

  • How Attys Can Use AI To Surface Narratives In E-Discovery

    Author Photo

    E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.

  • DOJ Enforcement Trends To Watch In 2nd Half Of 2025

    Author Photo

    Recent investigations, settlements and a declination to prosecute suggest that controlling the flow of goods into and out of the country, and redressing what the administration sees as reverse discrimination, are likely to be at the forefront of the U.S. Department of Justice's enforcement agenda the rest of this year, say attorneys at Baker Botts.

  • Purdue Case Could Transform Patent Obviousness Analyses

    Author Photo

    If accepted for review by the U.S. Supreme Court, Purdue Pharma v. Accord Healthcare — concerning whether Purdue's abuse-deterrent opioid formulation patents were invalid as obvious — could significantly shift how courts weigh secondary considerations in patent obviousness analyses, say attorneys at Lathrop.

  • NM Cyber Ruling Will Spur Litigation As Coverage Remedy

    Author Photo

    In Kane v. Beazley, the New Mexico Court of Appeals recently found that a cyber liability provision insuring security breaches included coverage for funds transfer fraud, implicitly and incorrectly motivating policyholders to commence litigation to avoid contractual limitations on cyber coverages, say attorneys at Zelle.

  • Law School's Missed Lessons: Practicing Self-Care

    Author Photo

    Law schools don’t teach the mental, physical and emotional health maintenance tools necessary to deal with the profession's many demands, but practicing self-care is an important key to success that can help to improve focus, manage stress and reduce burnout, says Rachel Leonard​​​​​​​ at MG+M.

  • New Laws Show How States Are Checking AI Developers

    Author Photo

    Recent state consumer protection legislation shows Utah, Colorado and Texas are primed to impose controls on artificial intelligence, and exemplifies the states' unwillingness to accord strong deference to developers and deployers of AI tools, say attorneys at Polsinelli.

  • ABA Opinion Makes It A Bit Easier To Drop A 'Hot Potato'

    Author Photo

    The American Bar Association's recent ethics opinion clarifies when attorneys may terminate clients without good cause, though courts may still disqualify a lawyer who drops a client like a hot potato, so sending a closeout letter is always a best practice, say attorneys at Thompson Hine.

  • IPR Denial In IRhythm Should Not Set A Blanket Rule

    Author Photo

    Though the Patent Trial and Appeal Board's discretionary denial in iRhythm v. Welch Allyn last month raised concerns that mere knowledge of a patent could bar inter partes review institution, a closer look at the facts and reasoning reveals why this case's holdings should not be reflexively applied to all petitioners, says David McCombs at Haynes Boone.

  • 8 Ways Lawyers Can Protect The Rule Of Law In Their Work

    Author Photo

    Whether they are concerned with judicial independence, regulatory predictability or client confidence, lawyers can take specific meaningful actions on their own when traditional structures are too slow or too compromised to respond, says Angeli Patel at the Berkeley Center of Law and Business.

  • Law School's Missed Lessons: Communicating With Clients

    Author Photo

    Law school curricula often overlook client communication procedures, and those who actively teach this crucial facet of the practice can create exceptional client satisfaction and success, says Patrick Hanson at Wiggam Law.

  • Adapting To Private Practice: From US Rep. To Boutique Firm

    Author Photo

    My transition from serving as a member of Congress to becoming a partner at a boutique firm has been remarkably smooth, in part because I never stopped exercising my legal muscles, maintained relationships with my former colleagues and set the right tone at the outset, says Mondaire Jones at Friedman Kaplan.

Can't find the article you're looking for? Click here to search the Healthcare Authority Other archive.